Keywords
Pharmaceutical industryScrutinyAttritionProductivitySubject (documents)PoliticsPerspective (graphical)Face (sociological concept)Public economicsHealth careBusinessDrug industryEconomic policyDrug pricesEconomicsPolitical scienceEconomic growthMedicineLawPharmacologyEngineeringSociologySocial science
Affiliated Institutions
Related Publications
Diagnosing the decline of major pharmaceutical research laboratories: A prescription for drug companies
Abstract Despite dramatically increasing expenditures for in‐house pharmaceutical research and development (R&D) at major drug companies, few internally discovered, breakthr...
Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018
Importance The mean cost of developing a new drug has been the subject of debate, with recent estimates ranging from $314 million to $2.8 billion. Objective To estimate the rese...
Incentives to Innovate in Public and Private Organizations
This article uses the different perspectives of economic theory, organization theory, public administration, and political science to explore the question of whether public orga...
Publication Info
- Year
- 2004
- Type
- review
- Volume
- 3
- Issue
- 8
- Pages
- 711-716
- Citations
- 4035
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
4035
OpenAlex
Cite This
Ismail Kola,
J. Richard Landis
(2004).
Can the pharmaceutical industry reduce attrition rates?.
Nature Reviews Drug Discovery
, 3
(8)
, 711-716.
https://doi.org/10.1038/nrd1470
Identifiers
- DOI
- 10.1038/nrd1470